Nashville, TN – According to filings with the U.S. Securities and Exchange Commission, Monogram Health is raising $168,021,254.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Michael Uchrin played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Monogram Health
We focus exclusively on kidney disease and deploy a broad array of AI-enabled services that generate industry leading outcomes by providing personalized, compassionate, and evidence-based care in the home. Our nurses and support team will work with you and your doctor to create a plan for care that is tailored to your unique needs and aimed at keeping you as healthy and comfortable as possible. A core tenant of our care model is making visits to your home. We know it can be a challenge to get to the doctor’s office, and most of our are patients are grateful that we are so committed to seeing you in your home. Our renal disease focused managed services platform integrates leading nephrologists, frontier technologies and local clinical care teams to improve lives and reduce costs through the delivery of personalized and compassionate care in the home. We are proud to have doubled planned dialysis transitions, tripled rates of home dialysis, and halved readmission rates from the national average for our current plan partners.

To learn more about Monogram Health, visit http://www.monogramhealthcare.com/

Contact:
Michael Uchrin, President and Chief Executive Officer
615-619-1070
michael.uchrin@monogramhealthcare.com
https://www.linkedin.com/in/mike-uchrin-0b53791/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved